Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Revance Therapeutics, Inc. | d662955d10k.htm |
| EX-31.1 - EX-31.1 - Revance Therapeutics, Inc. | d662955dex311.htm |
| EX-31.2 - EX-31.2 - Revance Therapeutics, Inc. | d662955dex312.htm |
| EX-21.1 - EX-21.1 - Revance Therapeutics, Inc. | d662955dex211.htm |
| EX-32.2 - EX-32.2 - Revance Therapeutics, Inc. | d662955dex322.htm |
| EX-10.26 - EX-10.26 - Revance Therapeutics, Inc. | d662955dex1026.htm |
| EX-10.31 - EX-10.31 - Revance Therapeutics, Inc. | d662955dex1031.htm |
| EX-32.1 - EX-32.1 - Revance Therapeutics, Inc. | d662955dex321.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-193963 ) of Revance Therapeutics, Inc. of our report dated March 28, 2014 relating to the financial statements which appear in this Form 10-K.
| /s/ PricewaterhouseCoopers LLP |
| San Jose, CA |
| March 28, 2014 |